메뉴 건너뛰기




Volumn 59, Issue 4, 2016, Pages 188-195

An analysis of the factors affecting the changes in medical expenses over the past 5 years in the management of out-patients with type 2 diabetes mellitus

Author keywords

Body mass index; HbAlc

Indexed keywords


EID: 84968830299     PISSN: 0021437X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (1)

References (12)
  • 1
    • 84968756996 scopus 로고    scopus 로고
    • accessed on 9 June, 2015
    • (http://www.mhlw.go.jp/toukei/saikin/liw/k-iryohi/l 2/dl/data.pdf, accessed on 9 June, 2015)
  • 2
    • 84936953757 scopus 로고    scopus 로고
    • Anagliptin in the treatment of type 2 diabetes: Safety, efficacy, and patient acceptability
    • Nishio S, Abe M, Ito H (2015) Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability. Diabetes Metab Syndr Obes 2015 8:163-171
    • (2015) Diabetes Metab Syndr Obes 2015 , vol.8 , pp. 163-171
    • Nishio, S.1    Abe, M.2    Ito, H.3
  • 3
    • 33746341543 scopus 로고    scopus 로고
    • Impact of overweight and obesity on medical care costs, all-cause mortality, and the risk of cancer in Japan
    • Kuriyama S (2006) Impact of overweight and obesity on medical care costs, all-cause mortality, and the risk of cancer in Japan. I Epidemiol 16:139-144
    • (2006) I Epidemiol , vol.16 , pp. 139-144
    • Kuriyama, S.1
  • 4
    • 35648988914 scopus 로고    scopus 로고
    • Medical costs of obese Japanese: A 10-year follow-up study of National Health Insurance in Shiga, Japan
    • Nakamura K, Okamura T, Kanda H, Hayakawa T, Okayama A, Ueshima H; Health Promotion Research Committee of the Shiga National Health Insurance Organizations (2007) Medical costs of obese Japanese: a 10-year follow-up study of National Health Insurance in Shiga, Japan. Eur J Public Health 17:424-429
    • (2007) Eur J Public Health , vol.17 , pp. 424-429
    • Nakamura, K.1    Okamura, T.2    Kanda, H.3    Hayakawa, T.4    Okayama, A.5    Ueshima, H.6
  • 5
    • 84968931943 scopus 로고    scopus 로고
    • accessed on 9 June, 2015
    • (http://www.mhlw.go.jp/file/04-Houdouhapp you-10904750-Kenkoukyoku-Gantaisakukenkouzoushi nka/0000068070.pdf, accessed on 9 June, 2015)
  • 6
    • 84968800342 scopus 로고    scopus 로고
    • (http://jddm.jp/data/index.html)
  • 7
    • 77950264381 scopus 로고    scopus 로고
    • High frequencies of diabetic micro- and macroangiopathies in patients with type 2 diabetes mellitus with decreased estimated glomerular filtration rate and normoalbuminuria
    • Ito H, Takeuchi Y, Ishida H, Antoku S, Abe M, Mifune M, Togane M (2010) High frequencies of diabetic micro- and macroangiopathies in patients with type 2 diabetes mellitus with decreased estimated glomerular filtration rate and normoalbuminuria. Nephrol Dial Transplant 25:1161-1167
    • (2010) Nephrol Dial Transplant , vol.25 , pp. 1161-1167
    • Ito, H.1    Takeuchi, Y.2    Ishida, H.3    Antoku, S.4    Abe, M.5    Mifune, M.6    Togane, M.7
  • 8
    • 84859220204 scopus 로고    scopus 로고
    • Hyperuricemia is independently associated with coronary heart disease and renal dysfunction in patients with type 2 diabetes mellitus
    • Ito H, Abe M, Mifune M, Oshikiri K, Antoku S, Takeuchi Y, Togane M (2011) Hyperuricemia is independently associated with coronary heart disease and renal dysfunction in patients with type 2 diabetes mellitus. PLoS One 6:e27817
    • (2011) PLoS One , vol.6 , pp. e27817
    • Ito, H.1    Abe, M.2    Mifune, M.3    Oshikiri, K.4    Antoku, S.5    Takeuchi, Y.6    Togane, M.7
  • 9
    • 84863780030 scopus 로고    scopus 로고
    • The usefulness of the revised classification for chronic kidney disease by the KDIGO for determining the frequency of diabetic micro- and macroangiopathies in Japanese patients with type 2 diabetes mellitus
    • Ito H, Oshikiri K, Mifune M, Abe M, Antoku S, Takeuchi Y, Togane M, Yukawa C (2012) The usefulness of the revised classification for chronic kidney disease by the KDIGO for determining the frequency of diabetic micro- and macroangiopathies in Japanese patients with type 2 diabetes mellitus. J Diabetes Complications 26:286-290
    • (2012) J Diabetes Complications , vol.26 , pp. 286-290
    • Ito, H.1    Oshikiri, K.2    Mifune, M.3    Abe, M.4    Antoku, S.5    Takeuchi, Y.6    Togane, M.7    Yukawa, C.8
  • 10
    • 84886729115 scopus 로고    scopus 로고
    • The prevalence of the risk factors for atherosclerosis among type 2 diabetic patients is greater in the progressive stages of chronic kidney disease
    • Ito H, Antoku S, Furusho M, Shinozaki M, Abe M, Mifune M, Togane M, Ito K, Sanaka T (2013) The prevalence of the risk factors for atherosclerosis among type 2 diabetic patients is greater in the progressive stages of chronic kidney disease. Nephron Extra 3:66-72
    • (2013) Nephron Extra , vol.3 , pp. 66-72
    • Ito, H.1    Antoku, S.2    Furusho, M.3    Shinozaki, M.4    Abe, M.5    Mifune, M.6    Togane, M.7    Ito, K.8    Sanaka, T.9
  • 11
    • 84892428499 scopus 로고    scopus 로고
    • The ratio of serum eicosapentaenoic acid to arachidonic acid is associated with renal impairment and diabetic macroangiopathies in elderly patients with type 2 diabetes
    • Ito H, Ohira H, Chinen T, Omoto T, Shinozaki M, Nishio S, Abe M, Antoku S, Mifune M, Toagane M (2014) The ratio of serum eicosapentaenoic acid to arachidonic acid is associated with renal impairment and diabetic macroangiopathies in elderly patients with type 2 diabetes. Diabetes Care 37:e7-8
    • (2014) Diabetes Care , vol.37 , pp. e7-e8
    • Ito, H.1    Ohira, H.2    Chinen, T.3    Omoto, T.4    Shinozaki, M.5    Nishio, S.6    Abe, M.7    Antoku, S.8    Mifune, M.9    Toagane, M.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.